Regulatory Compliance
CenterWatch | Insights
If My Study Includes Approved Drugs, When Do the Risks of Those Drugs Need to Be Disclosed in the Consent Form?
Blog Posts
CenterWatch | Insights
FDA’s Path Toward Diversity in Clinical Trials: The DEPICT Act and Sponsor Responsibility
Whitepapers
CenterWatch | Insights
Understanding the FDA’s new proposed regulations on human subject research and their impact on your clinical trial plans
Videos
CenterWatch | Insights
Assessing Potential Risks in the Consideration of IND Exemption Criteria
Blog Posts
CenterWatch | Insights
Defining “Minimal Risk” in Clinical Research
Blog Posts
CenterWatch | Insights
Should Parents Be Allowed to View their Child’s Survey Responses?
Blog Posts
CenterWatch | Insights
What are the requirements for notifications of study closure at research sites?
Blog Posts
CenterWatch | Insights
FDA Guidance Portal
Resource Hub
CenterWatch | Insights
The Basics of the Individual Expanded Access Request Process: A Resource for Physicians
Whitepapers
CenterWatch | Insights